Catherine Bowes Rickman

Catherine Bowes Rickman

Auto-generated profile, based on publicly available information

Catherine Bowes Rickman

Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1990 in Nature
Verified
Journal Article
Closed access
CBCathy Bowes
Cathy Bowes
TLTiansen Li
Tiansen Li
MDMichael Danciger
Michael Danciger
LBLeslie C. Baxter
Leslie C. Baxter
MAMeredithe L. Applebury
Meredithe L. Applebury
DFDebora B. Farber
Debora B. Farber

1 March 2010 in Progress in Retinal and Eye Research
Verified
Journal Article
Closed access
DADon H. Anderson
Don H. Anderson
MRMonte J. Radeke
Monte J. Radeke
NGNatasha B. Gallo
Natasha B. Gallo
ECEthan A. Chapin
Ethan A. Chapin
PJPatrick T. Johnson
Patrick T. Johnson
LJLincoln V. Johnson
Lincoln V. Johnson

30 October 2014 in Autophagy
Verified
Journal Article
Closed access
SMSayak K Mitter
Sayak K Mitter
CSChunjuan Song
Chunjuan Song
XQXiaoping Qi
Xiaoping Qi
HMHaoyu Mao
Haoyu Mao
HRHaripriya Rao
Haripriya Rao
Michael E. BoultonMichael E. Boulton
Michael E. Boulton
Autophagic dysregulation has been suggested in a broad range of neurodegenerative diseases including age-related macular degeneration (AMD). To test whether the autophagy pathway plays a critical role to protect retinal pigmented epithelial (RPE) cells against oxidative stress, we exposed ARPE-19 and primary cultured human RPE cells to both acute (3 and 24 h) and chronic (14 days) oxidative stress and monitored autophagy by western blot, PCR and autophagosome counts in the presence or absence of autophagy modulators. Acute oxidative stress led to a marked increase in autophagy in the RPE whereas autophagy was reduced under chronic oxidative stress. Upregulation of autophagy by rapamycin decreased oxidative stress-induced generation of reactive oxygen species (ROS), whereas inhibition of autophagy by 3-methyladenine (3-MA) or by knockdown of ATG7 or BECN1 increased ROS generation, exacerbated oxidative stress-induced reduction of mitochondrial activity, reduced cell viability and increased lipofuscin. Exam...

1 March 2019 in Immunity
Verified
Journal Article
Closed access
EOEmily G. O’kOren
Emily G. O’kOren
CYChen Yu
Chen Yu
MKMikael Klingeborn
Mikael Klingeborn
AWAlicia Yoke Wei Wong
Alicia Yoke Wei Wong
CPCameron L. Prigge
Cameron L. Prigge
DSDaniel Saban
Daniel Saban

26 July 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
JHJames T Handa
James T Handa
CRCathy Bowes Rickman
Cathy Bowes Rickman
ADAndrew D. Dick
Andrew D. Dick
MGMichael Gorin
Michael Gorin
JMJoan Miller
Joan Miller
LFLindsay Farrer
Lindsay Farrer
Age-related macular degeneration (AMD) is the most common cause of blindness among the elderly in the developed world. While treatment is effective for the neovascular or “wet” form of AMD, no therapy is successful for the non-neovascular or “dry” form. Here we discuss the current knowledge on dry AMD pathobiology and propose future research directions that would expedite the development of new treatments. In our view, these should emphasize system biology approaches that integrate omic, pharmacological, and clinical data into mathematical models that can predict disease onset and progression, identify biomarkers, establish disease causing mechanisms, and monitor response to therapy.

3 August 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
GMG. Malek
G. Malek
LJL. V. Johnson
L. V. Johnson
BMB. E. Mace
B. E. Mace
PSP. Saloupis
P. Saloupis
DSD. E. Schmechel
D. E. Schmechel
CRC. Bowes Rickman
C. Bowes Rickman
Age-related macular degeneration (AMD) is a late-onset, multifactorial, neurodegenerative disease of the retina and the leading cause of irreversible vision loss in the elderly in the Western world. We describe here a murine model that combines three known AMD risk factors: advanced age, high fat cholesterol-rich (HF-C) diet, and apolipoprotein E (apoE) genotype. Eyes of aged, targeted replacement mice expressing human apoE2, apoE3, or apoE4 and maintained on a HF-C diet show apoE isoform-dependent pathologies of differential severity. ApoE4 mice are the most severely affected. They develop a constellation of changes that mimic the pathology associated with human AMD. These alterations include diffuse sub-retinal pigment epithelial deposits, drusenoid deposits, thickened Bruch's membrane, and atrophy, hypopigmentation, and hyperpigmentation of the retinal pigment epithelium. In extreme cases, apoE4 mice also develop marked choroidal neovascularization, a hallmark of exudative AMD. Neither age nor HF-C diet alone is sufficient to elicit these changes. We document choroidal neovascularization and other AMD-like ocular pathologies in an animal model that exploits known AMD risk factors. The model is additionally attractive because it is not complicated by invasive experimental intervention. Our findings in this model implicate the human apoE E4 allele as a susceptibility gene for AMD and support the hypothesis that common pathogenic mechanisms may underlie AMD and Alzheimer's disease.